Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 37%
Hold 21%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is operating in an industry that is highly regulated, and there may be risks associated with Medicare and Medicaid. However, despite these risks, the company has a strong market position with a large network of hospitals and outpatient facilities, and is well-positioned for future growth. Management continues to focus on efficient operations and has a strong track record of generating solid cash flow and shareholder returns. The company's initial guidance for 2026 was solid with potential for additional upside from pending SDP approvals and a robust pipeline for outpatient opportunities. Overall, the positive financial outlook and strong fundamentals make HCA Healthcare a good investment opportunity.

Bears say

HCA Healthcare is facing significant headwinds in 2026, including a decline in exchange market volumes and a potential decline in utilization of care and shift toward ER usage. Additionally, the company's resiliency program, which aims to generate $400 million in savings, may not be enough to offset these challenges. Despite strong 4Q results, the company's outlook for 2026 includes a decrease in adjusted EBITDA due to these headwinds, and the stock's long-term average multiple of 9x may be difficult to maintain in the face of these challenges.

HCA Healthcare (HCA) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 37% recommend Buy, 21% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 19 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $523.68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $523.68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.